Oncology Data Advisor
Additional Advances in Triple-Negative Breast Cancer Research and Trials: Sara M. Tolaney, MD, MPH
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:07:22
- More information
Informações:
Synopsis
Last year, Dr. Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, served as co-chair of i3 Health’s webinar and online activity, Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC). With numerous advances in TNBC research occurring since then, Dr. Tolaney sat down with Oncology Data Advisor to share additional updates from clinical trials and a preview into the future of treatment with emerging therapies for TNBC.
